Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,254 | -44,348 | -27,236 | -21,698 | -11,295 |
| Depreciation Amortization | -400 | -300 | 324 | 233 | 86 |
| Accounts receivable | N/A | 3,078 | -1,863 | 482 | -1,697 |
| Accounts payable and accrued liabilities | 2,583 | 239 | 164 | -8 | -169 |
| Other Working Capital | 7,104 | 7,201 | -198 | 1,450 | -1,333 |
| Other Operating Activity | 3,275 | 1,937 | 4,194 | 701 | 3,426 |
| Operating Cash Flow | $-65,692 | $-32,193 | $-24,615 | $-18,840 | $-10,982 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -247 | -14,809 | -21,910 | -11,944 | -3,766 |
| PPE Investments | -1,492 | -422 | -619 | -212 | -208 |
| Other Investing Activity | 0 | 0 | 0 | 80 | -40 |
| Investing Cash Flow | $-1,739 | $-15,231 | $-22,529 | $-12,076 | $-4,014 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -25 | 0 | 0 | N/A | N/A |
| Common Stock Issued | 65,748 | 57,068 | 12,213 | 49,370 | -2,005 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 43,679 |
| Financing Cash Flow | $65,723 | $57,068 | $12,213 | $49,370 | $41,674 |
| Beginning Cash Position | 22,461 | 12,817 | 47,748 | 29,294 | 2,616 |
| End Cash Position | 20,753 | 22,461 | 12,817 | 47,748 | 29,294 |
| Net Cash Flow | $-1,708 | $9,644 | $-34,931 | $18,454 | $26,678 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,692 | -32,193 | -24,615 | -18,840 | -10,982 |
| Capital Expenditure | -1,492 | -422 | -619 | -212 | -208 |
| Free Cash Flow | -67,184 | -32,615 | -25,234 | -19,052 | -11,190 |